Efficacy and safety of ritlecitinib in Chinese patients with alopecia areata: A single-centre real-world study
Published: 17 February 2025| Version 1 | DOI: 10.17632/nfm87k6jm5.1
Contributors:
, Wang QinDescription
Supplementary Figure of Efficacy and Safety of Ritlecitinib in Chinese Patients with Alopecia Areata: A Single-Center Real-World Study.
Files
Institutions
Huashan Hospital Fudan University
Categories
Hair Disorder